| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $80.1M | +28.1% |
| SG&A Expense | $24.1M | +38.3% |
| Operating Income | -$104.2M | -30.3% |
| Income Tax | $0 | — |
| Net Income | -$86.5M | -25.1% |
| EPS (Basic) | -$1.51 | +6.8% |
| EPS (Diluted) | -$1.51 | +6.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.0M | +58.5% |
| Current Assets | $347.5M | +64.2% |
| Total Assets | $363.6M | +61.0% |
| Current Liabilities | $14.6M | -4.8% |
| Total Liabilities | $20.4M | -5.5% |
| Stockholders' Equity | $343.2M | +68.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.8M | -39.2% |
| Capital Expenditures | $664K | -13.8% |
| Investing Cash Flow | -$98.4M | +32.0% |
| Financing Cash Flow | $202.1M | — |
| Free Cash Flow | -$70.4M | -38.4% |